ES009

· Elpiscience Biopharma Australia Pty. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ES009, covering 2025-06-23 to 2025-06-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ES009 in Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 1]